Effect of initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension on ambulatory blood pressure

J. M. Nolde, E. Atkins, S. Marschner, G. S. Hillis, J. Chalmers, L. Billot, M. R. Nelson, C. M. Reid, P. Hay, Michael Burke, S. Jansen, T. Usherwood, A. Rodgers, C. K. Chow, M. P. Schlaich

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

Hypertension management remains suboptimal globally, with treatment inertia being identified as one of the main barriers to achieving blood pressure (BP) control. Simpler approaches to achieve target BP levels are needed. The QUARTET study (Quadruple Ultra-Low-Dose Treatment for Hypertension) demonstrated that a single-pill combination of 4 BP-lowering medications at ultra-low (quarter) doses is more effective in reducing and maintaining lower unattended office BP than initial monotherapy with uptitration if needed. This Research Letter summarizes key, prespecified, secondary outcomes from 24-hour ambulatory BP monitoring (ABPM) performed at baseline and at 52 weeks of extended follow-up.
Original languageEnglish
Pages (from-to)375-377
Number of pages3
JournalCirculation
Volume148
Issue number4
DOIs
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'Effect of initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension on ambulatory blood pressure'. Together they form a unique fingerprint.

Cite this